Skip to main content

Advertisement

Table 1 Baseline characteristics of patients

From: Radiotherapy cannot prolong overall survival of young prostate cancer patients with bone metastases

  RT Non-RT P value
Age 64.26 ± 4.98 63.96 ± 5.48 0.788
Gleason score 7.91 ± 1.31 7.88 ± 1.33 0.913
PSA 323.05 ± 529.83 368.14 ± 613.40 0.713
ALP 304.32 ± 455.35 316.52 ± 346.32 0.884
Chemotherapy    0.162
 Yes 9 (25.71 %) 10 (14.49 %)  
 No 26 (74.29 %) 59 (85.51 %)  
The number of bone metastases    0.975
 Single 6 (17.14 %) 12 (17.39 %)  
 Multiple 29 (82.86 %) 57 (82.61 %)  
Regional lymph node metastasis    0.002
 Yes 1 (2.86 %) 20 (28.99 %)  
 No 34 (97.14 %) 49 (71.01 %)  
Other organ metastasis    0.09
 Yes 7 (20.00 %) 25 (36.23 %)  
 No 28 (80.00 %) 44 (63.77 %)  
  1. PSA prostate-specific antigen; ALP alkaline phosphatase; RT radiotherapy